Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

Recruiting now

Conditions studied: Endometrial Carcinoma

In brief

This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions.

Key facts

Study ID

NCT06365905

Run by

Mayo Clinic

People needed

300

Starts

2024-03-27

Expected to finish

2027-06-30

Last updated by the study team

2026-06-10

Who can join

Age: 55 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 55 years
• At least one episode of postmenopausal bleeding (PMB)
• Endometrial biopsy available from at Mayo Clinic (MN, AZ, FL), Mayo Clinic Health System (MCHS), or an external institution
• Acceptance to participate in the study

You may not qualify if…

• Diagnostic tests performed more than 90 days apart
• Physical impediment/refusal to undergo transvaginal ultrasound (TVUS)

Where it is running

• Mayo Clinic in Arizona — Scottsdale, Arizona, United States (enrolling)
• Mayo Clinic in Florida — Jacksonville, Florida, United States (enrolling)
• Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.